Results 151 to 160 of about 97,210 (288)

First Report of Enterocytozoon bieneusi, Encephalitozoon spp. and Blastocystis spp. in Hair Goats in Türkiye

open access: yesZoonoses and Public Health, EarlyView.
ABSTRACT Introduction Blastocystis spp., Enterocytozoon bieneusi and Encephalitozoon spp. are prevalent zoonotic gastrointestinal parasites that cause severe diarrhoea and enteric diseases in humans and animals worldwide. This study investigated the molecular occurrence, genetic diversity and zoonotic potential of E. bieneusi, Blastocystis spp.
Zuhal Önder   +7 more
wiley   +1 more source

Trends in antibody seroprevalence.

open access: yes, 2012
Total seroprevalence for any HPV serotype and overall seroprevalence for the seven hr-HPV serotypes tested between the 1995–96 (blue bars) and 2006–07 (red bars) surveys.
Mirte Scherpenisse (120041)   +7 more
core   +1 more source

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 9, Page 2336-2346, 1 November 2026.
ABSTRACT The incidence of human papillomavirus‐positive (HPV+) oropharyngeal cancer (OPC) has increased rapidly, and HPV early antigen serology has been proposed as a scalable and cost‐effective early detection test. HPV seropositivity can precede clinical presentation of OPC by several years, so additional surveillance procedures may be necessary to ...
Lucas Penny   +23 more
wiley   +1 more source

Counting cases, conserving species: addressing highly pathogenic avian influenza in wildlife

open access: yesBiological Reviews, Volume 101, Issue 5, Page 2190-2213, October 2026.
ABSTRACT Highly pathogenic avian influenza (HPAI) has become a critical threat to wildlife, shifting from a seasonal epizootic to a persistent, year‐round panzootic with global consequences. Here, we summarise the origin, evolutionary mechanisms, and expanding host range of the current H5N1 virus (clade 2.3.4.4b) and assess its impact on wildlife. Over
Ulrich Knief   +4 more
wiley   +1 more source

COVID-19 seroprevalence surveys [PDF]

open access: yes
seroprevalence-surveys-for-COVID-19.pdfOverview of Seroprevalence Surveys for COVID-19 / Myrna Charles --Seroprevalence Surveys for COVID-19 Laboratory Considerations / Hetal Patel -- \u201cUNITY\u201d STUDIES : WHO early sero-epidemiological ...

core  

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 10, October 2026.
ABSTRACT The World Health Organisation aims to eliminate hepatitis C virus (HCV) infection as a public health threat by 2030. We assessed progress towards HCV elimination in Norway until the end of 2024. We used linked national registry data to describe diagnosed cases of HCV infection by treatment uptake and case characteristics, and the incidence of ...
Robert Whittaker   +4 more
wiley   +1 more source

Seroprevalence and risk factors of bluetongue virus in domestic cattle, sheep, goats and camels in Africa: a systematic review and meta-analysis

open access: yesVeterinary Quarterly
Bluetongue (BT) is a vector-borne disease affecting wild and domestic ruminants in many parts of the world. Although bluetongue virus (BTV) is widespread in ungulates in Africa, available epidemiological information on BT in this continent is limited ...
Bachir Medrouh   +12 more
doaj   +1 more source

High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate

open access: yes, 2000
OBJECTIVES \ud \ud To determine whether the seroprevalence of antibodies to varicella zoster virus (VZV) in adults is similar to that reported in tropical populations elsewhere.\ud \ud METHODS \ud \ud We measured the seroprevalence of VZV IgG antibodies,
O'Grady, Kerry-Ann   +7 more
core   +1 more source

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

open access: yes
Transfusion, EarlyView.
Thane Kubik   +2 more
wiley   +1 more source

EuroHePP: The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030.
Serena Fondelli   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy